APC anti-human TCR Vbeta8 [JR2 (JR.2)] and 3 more items

The University of Virginia awarded contract A207_PO-0446379 to BioLegend Inc. on June 6, 2026, for the procurement of specialized flow cytometry reagents totaling $797.00. The contract encompasses four distinct monoclonal antibody products designed for immunological research applications, including APC anti-human T cell receptor Vbeta8, Brilliant Violet 421 anti-rat CD90/mouse CD90.1, Brilliant Violet 510 anti-human interferon-gamma, and Brilliant Violet 785 anti-human CD62L. All materials are to be delivered to Ryan M Sangston at the University of Virginia in Virginia.

This procurement supports laboratory research requiring specialized immunological detection reagents. Each line item consists of a single unit purchase at varying price points, reflecting the differing specifications and fluorescent labeling of the antibody products. The contract represents a low-value acquisition typical of research supply procurement, with individual unit prices ranging from $144.75 to $313.50. As a University of Virginia contract award, this procurement falls under the institution's procurement authority rather than traditional state or local government contracting mechanisms.